Xpress Biologics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 62

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 7

Xpress Biologics General Information

Description

Operator of a contract manufacturing company intended to serve the pre-clinical productions sector. The company's systems include the design of microbial expression services, the development of the upstream and downstream processes and the development of quality controls for the production of recombinant proteins, antibody fragments and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Drug Discovery
Parent Company
Polyplus (Biotechnology)
Corporate Office
  • Accessia Pharma Site
  • Avenue du Parc Industriel, 89, Milmort
  • 4041 Herstal
  • Belgium
+32 04 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xpress Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xpress Biologics‘s full profile, request access.

Request a free trial

Xpress Biologics Patents

Xpress Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4363571-A1 Automated plasmid extraction Pending 02-Jul-2021 00000000000
AU-2022227943-A1 Method for purifying a protein of interest Pending 26-Feb-2021 00000000
CA-3209210-A1 Method for purifying a protein of interest Pending 26-Feb-2021 00000000
EP-4298106-A1 Method for purifying a protein of interest Pending 26-Feb-2021 00000000
EP-4298224-A2 Method for producing a periplasmic form of the protein crm197 Pending 26-Feb-2021 C07K14/34
To view Xpress Biologics’s complete patent history, request access »

Xpress Biologics Executive Team (4)

Name Title Board Seat Contact Info
Carola Jüstel Chief Executive Officer & Board Member
Christian Rodriguez Ph.D Co-Founder & Chief Operating Officer
Marc Daukandt Co-Founder & Chief Business Officer
Philippe Ledent Ph.D Co-Founder, Chief Scientific Officer & Scientific Manager
To view Xpress Biologics’s complete executive team members history, request access »

Xpress Biologics Board Members (3)

Name Representing Role Since
000000 0ü0000 Xpress Biologics Chief Executive Officer & Board Member 000 0000
0ü0000 00000 Xpress Biologics Chairman 000 0000
0é00 00000000 Xpress Biologics Board Member 000 0000
To view Xpress Biologics’s complete board members history, request access »

Xpress Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xpress Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xpress Biologics‘s full profile, request access.

Request a free trial

Xpress Biologics Subsidiaries (1)

Company Name Industry Location Founded
Accessia Pharma Laboratory Services (Healthcare) Herstal, Belgium 0000
To view Xpress Biologics’s complete subsidiaries history, request access »

Xpress Biologics FAQs

  • When was Xpress Biologics founded?

    Xpress Biologics was founded in 2013.

  • Who is the founder of Xpress Biologics?

    Christian Rodriguez Ph.D, Marc Daukandt, and Philippe Ledent Ph.D are the founders of Xpress Biologics.

  • Who is the CEO of Xpress Biologics?

    Carola Jüstel is the CEO of Xpress Biologics.

  • Where is Xpress Biologics headquartered?

    Xpress Biologics is headquartered in Herstal, Belgium.

  • What is the size of Xpress Biologics?

    Xpress Biologics has 62 total employees.

  • What industry is Xpress Biologics in?

    Xpress Biologics’s primary industry is BPO/Outsource Services.

  • Is Xpress Biologics a private or public company?

    Xpress Biologics is a Private company.

  • What is Xpress Biologics’s current revenue?

    The current revenue for Xpress Biologics is 000000.

  • How much funding has Xpress Biologics raised over time?

    Xpress Biologics has raised $2.06M.

  • Who are Xpress Biologics’s investors?

    BioWin and WBC Ventures have invested in Xpress Biologics.

  • When was Xpress Biologics acquired?

    Xpress Biologics was acquired on 07-Dec-2022.

  • Who acquired Xpress Biologics?

    Xpress Biologics was acquired by Polyplus (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »